Patents/Assignees

Vyripharm Enterprises, Inc.

1 patent in portfolio

US11554184utility2023
Synthetic Cannabinoid Combination Therapy Compositions and Methods for Personalized and Targeted Therapies Including the Treatment of Infectious Diseases
0 cites